BioCentury
ARTICLE | Company News

Supernus deal

August 3, 2009 7:00 AM UTC

Supernus sold its rights to future royalties on an undisclosed product to an undisclosed partner for about $35 million. Supernus, which was formed through the acquisition of product formulation and de...